In an effort to reallocate resources to its growing oncology focus in the face of shrinking COVID-19 vaccine sales, German ...
BioNTech, once celebrated for its COVID-19 vaccines, is grappling with falling demand, restructuring and the departure of its ...
The German company that pioneered one of the first mRNA coronavirus vaccines is halting production, handing the reins to ...
The payment is the third instalment paid to Berlin from the fund and is meant to support "reforms for a more efficient and ...
German vaccine manufacturer BioNTech, which became known around the world for its Covid-19 jab with Pfizer, is to close ...
Germany's BioNTech said on Tuesday it would close sites affecting up to 1,860 jobs and buy back up to $1 billion worth of ...
The closed sites include some that came with its $1.25 billion takeover of CureVac last year, and BioNTech has said it hopes ...
Hosted on MSN
COVID-19 in Germany: What did politicians learn?
Jens Spahn had been called as a witness but he must have felt like a defendant during his questioning by the parliamentary fact-finding commission. Spahn, Germany's health minister from 2018 to 2021, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results